Skip to main content
SpringerLink
Log in

Algorithm for DMARD tapering reduces drug costs

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hagen M, et al. Cost-effective Tapering Algorithm in Rheumatoid Arthritis Patients: Combination of Multibiomarker Disease Activity Score and Autoantibody Status. The Journal of Rheumatology : Dec 2018. Available from: URL: http://doi.org/10.3899/jrheum.180028

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Algorithm for DMARD tapering reduces drug costs. PharmacoEcon Outcomes News 819, 5 (2019). https://doi.org/10.1007/s40274-019-5544-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5544-z

Search

Navigation